Your 2026 4/20 Guide: From Survival to Success

Happy 4/20! Today feels different, doesn't it? The "Green Rush" of the early 2020s—characterized by wild speculation and a "move fast and break things" mentality—has been replaced by a resilient industry.

In 2026, we aren't just celebrating a plant; we’re celebrating a multi-billion-dollar sector that has survived the gauntlet of high taxes, shifting politics, and a global economic reset. The story of 2026 is one of institutionalization. The pioneers who built this industry in the shadows are now sharing the stage with seasoned C-suite executives and institutional analysts.

As we stand on the precipice of the most significant regulatory shift in a generation, two primary paths have emerged for those looking to invest in the next cannabis era.

1. The American Engine: AdvisorShares Pure US Cannabis ETF (MSOS)

If you believe the real growth is happening right here in the States, MSOS is your primary vehicle. It made history as the first ETF to offer exclusive exposure to U.S. Multi-State Operators (MSOs)—the companies growing, processing, and retailing cannabis within state lines.

•  The People Factor: This ETF tracks the Multi-State Operators (MSOs)—the boots-on-the-ground companies like Curaleaf and Green Thumb Industries. These are the teams managing thousands of employees, complex supply chains, and the evolving social equity programs across the States. 
• The 2026 Context: For years, these companies were treated as second-class businesses by the federal government. MSOS captures the value of these domestic giants as they prepare for uplisting—the moment they can finally move from over-the-counter exchanges to major American exchanges on NYSE or Nasdaq. 

2. The Global Visionary: AdvisorShares Pure Cannabis ETF (YOLO)

While MSOS focuses on the U.S., offers a broader, more diversified global perspective on the sector. 

• The Strategy: YOLO recognizes that cannabis is a global opportunity. It balances the high-growth potential of the U.S. with the maturing Canadian producers and European biotech firms. 
• The Connection: Think of YOLO as a curated portfolio of some of the world’s best cannabis minds. It actually holds a significant position in MSOS (roughly 40–45%), meaning it offers a safety net of international selective diversification while still keeping its foot firmly on the gas of American retail. 

What's Changed and What Matters Now

• The Executive Push—Move to Schedule III

The industry is currently holding its breath as the Trump administration’s Executive Order to expedite rescheduling nears finalization. By directing the Attorney General to complete the move to Schedule III in an "expeditious manner," the administration has signaled that the era of treating cannabis like heroin is over.

The 280E Breakthrough:  For years, IRS code Section 280E* prevented cannabis businesses from deducting standard operating expenses. Schedule III ends that. This isn't just a paperwork change; it is a fundamental rewriting of the industry’s DNA, immediately injecting millions of dollars back into these companies' bottom lines.

• Closing the "Hemp Loophole"

As we move toward a more regulated future, the wild-west era of intoxicating hemp is coming to an end. Federal legislation passed in late 2025 has set a November 12, 2026 deadline to close the loophole that allowed Delta-8 and other synthetic intoxicants to sell without oversight.

The Funnel Effect:  Analysts expect the billions currently spent on unregulated hemp-derived products to funnel directly into the licensed legal market. * The Result: This shift is expected to clear the shelves of "gas station weed" and redirect that massive consumer demand toward the high-quality, tested products found in MSO-run dispensaries.

• Virginia: The 25th State on the Map

The map of legal America continues to grow. Virginia is officially slated to become the 25th state to launch a recreational program, with sales expected to begin on January 1, 2027. The Commonwealth’s entry is a major milestone for the South, opening up a massive new market of millions of consumers. For investors in ETFs like MSOS, Virginia represents a fresh "blue ocean" opportunity for MSOs who have already been laying the groundwork with medical infrastructure in the state.